• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.

作者信息

Delsol G, Lamant L, Mariamé B, Pulford K, Dastugue N, Brousset P, Rigal-Huguet F, al Saati T, Cerretti D P, Morris S W, Mason D Y

机构信息

Department of Pathology, CHU Purpan, Toulouse, France.

出版信息

Blood. 1997 Mar 1;89(5):1483-90.

PMID:9057627
Abstract

Seven cases of large B-cell lymphoma which define a previously unrecognized subgroup are reported. Morphologically they are comprised of monomorphic large immunoblast-like cells, containing large central nucleoli, which tend to invade lymphatic sinuses. Superficially they resemble anaplastic large cell lymphoma (ALCL) but they lack CD30. These lymphomas express epithelial membrane antigen (as do ALCL), but also contain intracytoplasmic IgA of a single light chain type (five cases) and an endoplasmic reticulum-associated marker detected by antibody VS38. They lack lineage-associated leukocyte antigens with the exception of CD4 (5 of 5 cases) and CD57 (5 of 7 cases). They are labeled by antibodies detecting both the intracytoplasmic and extracellular regions of the ALK receptor kinase, suggesting that they express the full-length form of this molecule. This was confirmed by Western blotting (in the one case tested) which showed a band of 200 kD in tumor cell lysates, and by polymerase chain reaction (PCR) amplification of mRNA encoding intracellular and extracellular ALK sequences (in the two cases tested). There was no evidence by cytogenetics (one case analyzed) or reverse transcriptase-PCR (three cases tested) of the 2; 5 translocation or the resultant NPM-ALK gene, as is commonly found in ALCL. All but one of the patients were male and all but one were adults, and in all but the latter case the disease followed an aggressive course.

摘要

相似文献

1
A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.
Blood. 1997 Mar 1;89(5):1483-90.
2
Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.通过逆转录-聚合酶链反应分析2号和5号染色体易位(t(2;5)(p23;q35))在CD30阳性间变性大细胞淋巴瘤、其他T细胞表型的非霍奇金淋巴瘤以及霍奇金病中的情况。
Blood. 1995 Sep 15;86(6):2321-8.
3
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.基因组DNA扩增显示间变性大细胞淋巴瘤中存在t(2;5)(p23;q35),但在其他非霍奇金淋巴瘤、霍奇金病或淋巴瘤样丘疹病中不存在。
Blood. 1996 Sep 1;88(5):1771-9.
4
Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.在CD30⁺原发性皮肤淋巴增殖性疾病和霍奇金病中缺乏t(2;5)或其他导致间变性淋巴瘤激酶催化结构域表达的突变。
Blood. 1996 Sep 1;88(5):1765-70.
5
The t(2;5) in human lymphomas.人类淋巴瘤中的t(2;5)
Leuk Lymphoma. 1998 Apr;29(3-4):249-56. doi: 10.3109/10428199809068562.
6
The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.单克隆抗体ALK1可识别一种与2p23/ALK重排相关的间变性大细胞淋巴瘤的独特形态学亚型。
Am J Pathol. 1997 Aug;151(2):343-51.
7
The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.在非肿瘤细胞中可检测到NPM-ALK和ATIC-ALK融合基因。
Am J Pathol. 2001 Jun;158(6):2185-93. doi: 10.1016/S0002-9440(10)64690-1.
8
Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.使用单克隆抗体ALK1检测正常细胞和肿瘤细胞中的间变性淋巴瘤激酶(ALK)和核仁蛋白核磷蛋白(NPM)-ALK蛋白。
Blood. 1997 Feb 15;89(4):1394-404.
9
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.间变性大细胞淋巴瘤及其他淋巴瘤中NPM-ALK和变异融合基因的病理生物学
Leukemia. 2000 Sep;14(9):1533-59. doi: 10.1038/sj.leu.2401878.
10
Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.间变性大细胞淋巴瘤中t(2;5)的检测:石蜡包埋组织中免疫组化研究、荧光原位杂交和逆转录聚合酶链反应的比较
Am J Surg Pathol. 1999 Nov;23(11):1386-92. doi: 10.1097/00000478-199911000-00009.

引用本文的文献

1
Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell Neoplasms.人类和小鼠ALK阳性B细胞肿瘤的DNA甲基化谱比较分析
Genes Chromosomes Cancer. 2025 Jul;64(7):e70060. doi: 10.1002/gcc.70060.
2
CD20-Negative Large B-Cell Lymphomas: The Diagnostic Challenge of Tumors with Downregulation of Mature B-Cell Marker Expression.CD20阴性大B细胞淋巴瘤:成熟B细胞标志物表达下调肿瘤的诊断挑战
Int J Mol Sci. 2025 Aug 14;26(16):7843. doi: 10.3390/ijms26167843.
3
Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype.
间变性大细胞淋巴瘤诊断的分子见解:超越形态学和免疫表型
Int J Mol Sci. 2025 Jun 19;26(12):5871. doi: 10.3390/ijms26125871.
4
ALK in cancer: from function to therapeutic targeting.癌症中的间变性淋巴瘤激酶:从功能到治疗靶点
Nat Rev Cancer. 2025 May;25(5):359-378. doi: 10.1038/s41568-025-00797-9. Epub 2025 Mar 7.
5
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.NVL-655是一种对多种ALK突变癌蛋白具有选择性且能穿透血脑屏障的抑制剂,包括对劳拉替尼耐药的复合突变。
Cancer Discov. 2024 Dec 2;14(12):2367-2386. doi: 10.1158/2159-8290.CD-24-0231.
6
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression.ALK 阳性大 B 细胞淋巴瘤(ALK+LBCL)伴异常 CD3 表达。
J Hematop. 2024 Jun;17(2):109-114. doi: 10.1007/s12308-024-00582-x. Epub 2024 Apr 4.
7
Uncommon spinal involvement of ALK-positive anaplastic large cell lymphoma: A pediatric case report and literature review.ALK阳性间变性大细胞淋巴瘤罕见的脊柱受累情况:一例儿科病例报告及文献综述
Radiol Case Rep. 2023 Nov 9;19(1):341-345. doi: 10.1016/j.radcr.2023.10.018. eCollection 2024 Jan.
8
fusion in ALK positive large B-cell lymphoma: a case report and review of literature.ALK阳性大B细胞淋巴瘤中的融合:一例病例报告及文献复习
Front Oncol. 2023 May 25;13:1174606. doi: 10.3389/fonc.2023.1174606. eCollection 2023.
9
Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma.间变性淋巴瘤激酶阳性大B细胞淋巴瘤原发性难治性患者使用间变性淋巴瘤激酶抑制剂的持久反应。
Blood Adv. 2023 Jun 27;7(12):2912-2916. doi: 10.1182/bloodadvances.2022007537.
10
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.下一代ALK抑制剂在ALK阳性大B细胞淋巴瘤中具有高度活性。
Blood. 2022 Oct 20;140(16):1822-1826. doi: 10.1182/blood.2022015443.